This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Drug Delivery In Central Nervous System Diseases - Technologies, Markets And Companies

Treatment of ALS 152

Drug delivery in ALS 153

Gene and antisense therapy of amyotrophic lateral sclerosis 154

Neurotrophic factor gene therapies of ALS 154

Antisense therapy of ALS 155

RNAi therapy of amyotrophic lateral sclerosis 155

Drug delivery for CNS involvement in Hunter syndrome 156

Cerebrovascular disease 156

Treatment of stroke 157

Drug delivery in stroke 157

Intraarterial administration of tissue plasminogen activator in stroke 158

Drug delivery for prevention of restenosis of carotid arteries 159

Modified NO donors 159

In-stent restenosis 160

Targeted local anti-restenotic drug delivery 160

Catheter-based drug delivery for restenosis 161

Stents for prevention of restenosis 161

Drug-eluting stents 162

Antisense approach to prevent restenosis 162

Drug-eluting stents for the treatment of intracranial atherosclerosis 163

Tissues transplants for stroke 163

Transplant of encapsulated tissue secreting neurotrophic factors 163

Cell therapy for stroke 163

Stem cell transplant into the brain 164

Immortalized cell grafts for stroke 164

Intravenous infusion of marrow stromal cells 165

Intravenous infusion of umbilical cord blood stem cells 165

Future of cell therapy for stroke 165

Gene therapy of cerebrovascular diseases 165

Gene transfer to cerebral blood vessels 166

NOS gene therapy for restenosis 167

Gene therapy for cerebral ischemia 167

Gene therapy of strokes with a genetic component 168

Drug delivery to intracranial aneurysms 169

Drug delivery for vasospasm following subarachnoid hemorrhage 169

Intrathecal tissue plasminogen activator 170

Gene therapy for vasospasm 171

Drug delivery in multiple sclerosis 172

An electronic device for self injection of interferon beta-1a 172

Oral therapies for MS 172

Antisense and RNAi approaches to MS 173

Cell therapy for multiple sclerosis 173

Hematopoietic stem cell transplantation for multiple sclerosis 173

Embryonic stem cells and neural precursor cells for MS 174

Gene therapy for multiple sclerosis 174

Drug delivery in epilepsy 175

Routes of administration of antiepileptic drugs 175

9 of 12

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.25 +19.09 0.95%
NASDAQ 4,683.4070 +45.4130 0.98%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs